Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Parrott

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Neuropsychobiology|January 1, 1992
Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasksA C Parrott, D Craig
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Smoking deprivation and cigarette reinstatement: effects upon visual attentionA C Parrott, G Roberts
Behavioural Pharmacology|April 26, 2000
Daily uplifts, hassles, stresses and cognitive failures: in cigarette smokers, abstaining smokers, and non-smokersA C Parrott, F J Kaye
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to ColeH C Fox, A C Parrott
Neuropsychobiology|June 27, 2000
'Is MDMA a human neurotoxin?': diverse views from the discussantsJ J Turner, A C Parrott
Psychopharmacology|January 1, 1992
Stress and arousal in sedative and stimulant cigarette smokersS T O'Neill, A C Parrott
Perceptual and Motor Skills|September 14, 1999
Multiple drug use and dietary restraint in a Mr. Universe competitor: psychobiological effectsC Wilson-Fearon, A C Parrott
Journal of Clinical Pharmacology|November 1, 1979
The effects of an ergot alkaloid derivative (Hydergine) on aspects of psychomotor performance, arousal, and cognitive processing abilityI Hindmarch, A C Parrott, M Lanza
British Journal of Clinical Pharmacology|April 1, 1977
A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjectsI Hindmarch, A C Parrott, L Arenillas
Human Psychopharmacology|June 29, 2017
Novel psychoactive substances: Shedding new lights on the ever-changing drug scenario and the associated health risksO Corazza, A C Parrott, Z Demetrovics
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Neuropsychobiology|January 1, 1992
Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasksA C Parrott, D Craig
Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Smoking deprivation and cigarette reinstatement: effects upon visual attentionA C Parrott, G Roberts
Behavioural Pharmacology|April 26, 2000
Daily uplifts, hassles, stresses and cognitive failures: in cigarette smokers, abstaining smokers, and non-smokersA C Parrott, F J Kaye
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to ColeH C Fox, A C Parrott
Neuropsychobiology|June 27, 2000
'Is MDMA a human neurotoxin?': diverse views from the discussantsJ J Turner, A C Parrott
Psychopharmacology|January 1, 1992
Stress and arousal in sedative and stimulant cigarette smokersS T O'Neill, A C Parrott
Perceptual and Motor Skills|September 14, 1999
Multiple drug use and dietary restraint in a Mr. Universe competitor: psychobiological effectsC Wilson-Fearon, A C Parrott
Journal of Clinical Pharmacology|November 1, 1979
The effects of an ergot alkaloid derivative (Hydergine) on aspects of psychomotor performance, arousal, and cognitive processing abilityI Hindmarch, A C Parrott, M Lanza
British Journal of Clinical Pharmacology|April 1, 1977
A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjectsI Hindmarch, A C Parrott, L Arenillas
Human Psychopharmacology|June 29, 2017
Novel psychoactive substances: Shedding new lights on the ever-changing drug scenario and the associated health risksO Corazza, A C Parrott, Z Demetrovics
Pageof 8